Form 4 Tracker
CYTOKINETICS INC
CYTK

65 insider filings · Latest: Jun 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 1 8:54 PMROBERT BLUM
Proposed Sale
52,500$85.19$4.5M

View →

Jun 24, 2026Jun 29 10:05 PMSung LeeEVP, Chief Financial Officer
Sale
38,730$82.30$3.2M63,221(D)

View →

Jun 29, 2026Jun 29 9:23 PMSung LeeEVP, Chief Financial Officer
Sale
3,134$85.00$266.4K63,221(D)

View →

Jun 29, 2026Jun 29 8:48 PMSung Lee
Proposed Sale
9,503$82.19$781.1K

View →

Jun 26, 2026Jun 26 8:24 PMSung Lee
Proposed Sale
6,695$80.80$541.0K

View →

Jun 24, 2026Jun 24 8:37 PMSung Lee
Proposed Sale
38,730$80.01$3.1M

View →

Jun 23, 2026Jun 23 9:41 PMFady Ibraham MalikEVP Research & Development
Sale
3,500$79.51$278.3K153,902(D)

View →

Jun 15, 2026Jun 15 8:40 PMRobert I BlumDirector, President & CEO
Sale
7,500$70.46$528.5K385,330(D)

View →

Jun 9, 2026Jun 9 9:40 PMFady Ibraham MalikEVP Research & Development
Sale
3,500$67.98$237.9K153,902(D)

View →

Jun 1, 2026Jun 1 10:54 PMEdward M. Kaye MDDirector
Sale
2,933$76.09$223.2K10,283(D)

View →

Jun 1, 2026Jun 1 10:51 PMAndrew CallosEVP, Chief Commercial Officer
Sale
15,000$74.08$1.1M58,555(D)

View →

Jun 1, 2026Jun 1 10:49 PMLynne B ParshallDirector
Sale
5,000$74.08$370.4K15,784(D)

View →

Jun 1, 2026Jun 1 8:17 PMEDWARD KAYE
Proposed Sale
2,933$76.76$225.1K

View →

May 27, 2026May 28 8:21 PMRobert I BlumDirector, President & CEO
Sale
7,500$77.21$579.1K392,830(D)

View →

May 19, 2026May 20 8:00 PMFady Ibraham MalikEVP Research & Development
Sale
3,500$75.69$264.9K153,902(D)

View →

May 14, 2026May 14 8:26 PMRobert I BlumDirector, President & CEO
Sale
7,500$77.92$584.4K400,330(D)

View →

May 5, 2026May 5 9:35 PMFady Ibraham MalikEVP Research & Development
Sale
3,500$77.37$270.8K153,902(D)

View →

May 5, 2026May 5 8:33 PMWENDELL WIERENGA
Proposed Sale
4,032$66.05$266.3K

View →

May 5, 2026May 5 8:31 PMJOHN HENDERSON
Proposed Sale
20,000$66.05$1.3M

View →

May 5, 2026May 5 8:31 PMSUNG LEE
Proposed Sale
23,906$66.05$1.6M

View →

Page 1 of 6

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 24, 2026Jun 29 10:05 PMSung LeeEVP, Chief Financial Officer
Option Exercise
38,730$48.5127,821(D)

View →

Jun 29, 2026Jun 29 9:23 PMSung LeeEVP, Chief Financial Officer
Option Exercise
3,134$48.5139,681(D)

View →

Jun 23, 2026Jun 23 9:41 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8040,886(D)

View →

Jun 9, 2026Jun 9 9:40 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8044,386(D)

View →

Jun 1, 2026Jun 1 10:51 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,000$23.2639,000(D)

View →

May 27, 2026May 27 11:16 PMMuna BhanjiDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:14 PMJames M DalyDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:13 PMRobert Arthur HarringtonDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:12 PMJohn T HendersonDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:11 PMEdward M. Kaye MDDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:10 PMLynne B ParshallDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:09 PMRobert E LandryDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:08 PMWendell WierengaDirector
Grant/Award
4,301$77.154,301(D)

View →

May 27, 2026May 27 11:07 PMNancy WysenskiDirector
Grant/Award
4,301$77.154,301(D)

View →

May 19, 2026May 20 8:00 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8047,886(D)

View →

May 5, 2026May 5 9:35 PMFady Ibraham MalikEVP Research & Development
Option Exercise
3,500$7.8051,386(D)

View →

May 5, 2026May 5 8:20 PMWendell WierengaDirector
Option Exercise
4,032$12.400(D)

View →

May 5, 2026May 5 8:15 PMJohn T HendersonDirector
Option Exercise
20,000$7.610(D)

View →

May 5, 2026May 5 8:11 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
11,333$39.1313,070(D)

View →

May 1, 2026May 4 8:01 PMAndrew CallosEVP, Chief Commercial Officer
Option Exercise
15,857$37.630(D)

View →

Page 1 of 2

Next →